ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Investigation of Hippo pathway-related prognostic lncRNAs and molecular subtypes in liver hepatocellular carcinoma

Su, Qiongfei; Hua, Fengyang; Xiao, Wanying; Liu, Baoqiu; Wang, Dongxia*; Qin, Xintian*广东药学院; 南方医科大学; 1; 东莞市人民医院
Scientific Reports2023-3-20DOI: 10.1038/s41598-023-31754-x
12阅读
引用收藏
分享

摘要

This study aimed to investigate Hippo pathway-related prognostic long noncoding RNAs (lncRNAs) and their prognostic value in liver hepatocellular carcinoma (LIHC). Expression and clinical data regarding LIHC were acquired from The Cancer Genome Atlas and European Bioinformatics Institute array databases. Hippo pathway-related lncRNAs and their prognostic value were revealed, followed by molecular subtype investigations. Differences in survival, clinical characteristics, immune cell infiltration, and checkpoint expression between the subtypes were explored. LASSO regression was used to determine the most valuable prognostic lncRNAs, followed by the establishment of a prognostic model. Survival and differential expression analyses were conducted between two groups (high- and low-risk). A total of 313 Hippo pathway-related lncRNAs were identified from LIHC, of which 88 were associated with prognosis, and two molecular subtypes were identified based on their expression patterns. These two subtypes showed significant differences in overall survival, pathological stage and grade, vascular invasion, infiltration abundance of seven immune cells, and expression of several checkpoints, such as CTLA-4 and PD-1/L1 (P < 0.05). LASSO regression identified the six most valuable independent prognostic lncRNAs for establishing a prognosis risk model. Risk scores calculated by the risk model assigned patients into two risk groups with an AUC of 0.913 and 0.731, respectively, indicating that the high-risk group had poor survival. The risk score had an independent prognostic value with an HR of 2.198. In total, 3007 genes were dysregulated between the two risk groups, and the expression of most genes was elevated in the high-risk group, involving the cell cycle and pathways in cancers. Hippo pathway-related lncRNAs could stratify patients for personalized treatment and predict the prognosis of patients with LIHC.

学科与关键词

关键词
T-CELLSCANCER
相关
加载中…
  • Inflammatory Response-Related Long Non-Coding RNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
    Li, Xinyu; Zhang, Shuqiao; Zhang, Shijun; Kuang, Weihong; Tang, Chunzhi*Journal of Oncology, 2022, 2022: 9917244.被引 5
  • Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma
    Li, Xiaoyong; Lin, Jiaqong; Pan, Yuguo; Cui, Peng; Xia, Jintang*TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20: 15330338211041425.被引 1
  • Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma
    Deng, Min; Lin, Jia-Bao; Zhao, Rong-Ce; Li, Shao-Hua; Lin, Wen-Ping; Zou, Jing-Wen; Wei, Wei; Guo, Rong-Ping*BMC CANCER, 2021, 21(1): 1347.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Scientific Reports
发表日期
2023-03-20
卷期
第 13 卷, 第 1 期
页码
4521
DOI
10.1038/s41598-023-31754-x
语言
ENGLISH
成果收录
SCIE
资助标注
Medical Scientific Research Foundation of Guangdong Province [C2020079]

作者

  • S

    Su, Qiongfei (第一作者)

    1 · guangdong pharmaceut univ

  • H

    Hua, Fengyang

    1 · guangdong pharmaceut univ

查看全部 6 位作者收起作者
  • X

    Xiao, Wanying

    1 · guangdong pharmaceut univ

  • L

    Liu, Baoqiu

    1 · guangdong pharmaceut univ

  • W

    Wang, Dongxia (通讯)

    dongguan peoples hosp · southern med univ

  • Q

    Qin, Xintian (通讯)

    1 · guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417